| Year |
Citation |
Score |
| 2024 |
Fan J, Zhang Y, Li S, Li Q, Zi Q, Mou X, Zheng J, Wang X, Guo X, Chen J, Yu J. Immunogen characterization reveals an intrinsic hindrance in eliciting neutralizing antibodies against JN.1 variant. Iscience. 27: 110405. PMID 39108735 DOI: 10.1016/j.isci.2024.110405 |
0.59 |
|
| 2024 |
Zhu Z, Li S, Fan J, Shang S, Zhang Y, Zi Q, Zheng J, Wang D, Mou X, Liu K, Lv M, Yuan J, Wang Z, Yu J. Omicron breakthrough infected individuals show enhanced nasal antibody responses and preserved T cell responses against the EG.5.1 and BA.2.86. Journal of Medical Virology. 96: e29537. PMID 38497465 DOI: 10.1002/jmv.29537 |
0.591 |
|
| 2023 |
Fan J, Li S, Zhang Y, Zheng J, Wang D, Liao Y, Cui Z, Zhao D, Barouch DH, Yu J. Early Emerging SARS-CoV-2 Spike Mutants Are Diversified in Virologic Properties but Elicit Compromised Antibody Responses. Viruses. 15. PMID 38140642 DOI: 10.3390/v15122401 |
0.559 |
|
| 2014 |
Mulligan MJ, Bernstein DI, Frey S, Winokur P, Rouphael N, Dickey M, Edupuganti S, Spearman P, Anderson E, Graham I, Noah DL, Mangal B, Kim S, Hill H, Whitaker J, ... ... Li S, et al. Point-of-Use Mixing of Influenza H5N1 Vaccine and MF59 Adjuvant for Pandemic Vaccination Preparedness: Antibody Responses and Safety. A Phase 1 Clinical Trial. Open Forum Infectious Diseases. 1: ofu102. PMID 25734170 DOI: 10.1093/Ofid/Ofu102 |
0.391 |
|
| Show low-probability matches. |